Record Information |
---|
Version | 2.0 |
---|
Created at | 2023-07-12 22:57:34 UTC |
---|
Updated at | 2024-09-03 04:16:35 UTC |
---|
NP-MRD ID | NP0331709 |
---|
Natural Product DOI | https://doi.org/10.57994/0724 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Speciogynine |
---|
Description | Speciogynine belongs to the class of organic compounds known as vobasan alkaloids. These are alkaloids containing the vobasan skeleton. Speciogynine was first documented in 2020 (PMID: 32597657). Based on a literature review a significant number of articles have been published on Speciogynine (PMID: 33620222) (PMID: 35468648) (PMID: 33408731) (PMID: 35335999) (PMID: 34803709) (PMID: 34467758). |
---|
Structure | [H][C@]12CC3=C(NC4=CC=C(OC)C=C34)C(=O)C[C@]3([H])[C@@]1([H])CO[C@]([H])(N2C)[C@]31O[C@@H]1C InChI=1S/C21H24N2O4/c1-10-21(27-10)15-8-18(24)19-13(7-17-14(15)9-26-20(21)23(17)2)12-6-11(25-3)4-5-16(12)22-19/h4-6,10,14-15,17,20,22H,7-9H2,1-3H3/t10-,14-,15-,17+,20+,21-/m1/s1 |
---|
Synonyms | Not Available |
---|
Chemical Formula | C23H30N2O4 |
---|
Average Mass | 398.5030 Da |
---|
Monoisotopic Mass | 398.22056 Da |
---|
IUPAC Name | (1'S,2S,3R,14'R,16'S,19'R)-6'-methoxy-3,20'-dimethyl-17'-oxa-10',20'-diazaspiro[oxirane-2,15'-pentacyclo[14.3.1.0^{3,11}.0^{4,9}.0^{14,19}]icosane]-3'(11'),4',6',8'-tetraen-12'-one |
---|
Traditional Name | (1'S,2S,3R,14'R,16'S,19'R)-6'-methoxy-3,20'-dimethyl-17'-oxa-10',20'-diazaspiro[oxirane-2,15'-pentacyclo[14.3.1.0^{3,11}.0^{4,9}.0^{14,19}]icosane]-3'(11'),4',6',8'-tetraen-12'-one |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC[C@H]1CN2CCC3=C(NC4=CC=CC(OC)=C34)[C@@H]2C[C@@H]1\C(=C/OC)C(=O)OC |
---|
InChI Identifier | InChI=1S/C23H30N2O4/c1-5-14-12-25-10-9-15-21-18(7-6-8-20(21)28-3)24-22(15)19(25)11-16(14)17(13-27-2)23(26)29-4/h6-8,13-14,16,19,24H,5,9-12H2,1-4H3/b17-13+/t14-,16-,19-/m0/s1 |
---|
InChI Key | LELBFTMXCIIKKX-CYSPOEIOSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 1H NMR Spectrum (1D, 500 MHz, CDCl3, experimental) | n_oberli@uncg.edu | Not Available | Not Available | 2023-07-13 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, CDCl3, experimental) | n_oberli@uncg.edu | Not Available | Not Available | 2023-07-13 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, CDCl3, experimental) | n_oberli@uncg.edu | Not Available | Not Available | 2023-07-12 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, CDCl3, experimental) | n_oberli@uncg.edu | Not Available | Not Available | 2023-07-12 | View Spectrum |
| Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | Species Name | Source | Reference |
---|
speciosa | | |
|
---|
Chemical Taxonomy |
---|
Description | This compound belongs to the class of organic compounds known as vobasan alkaloids. These are alkaloids containing the vobasan skeleton. |
---|
Kingdom | Organic compounds |
---|
Super Class | Alkaloids and derivatives |
---|
Class | Vobasan alkaloids |
---|
Sub Class | Not Available |
---|
Direct Parent | Vobasan alkaloids |
---|
Alternative Parents | |
---|
Substituents | - Vobasan skeleton
- Secoiridoid-skeleton
- Monoterpenoid
- Aromatic monoterpenoid
- Indole or derivatives
- Indole
- Aryl alkyl ketone
- Aryl ketone
- Anisole
- Alkyl aryl ether
- Alpha-branched alpha,beta-unsaturated-ketone
- Benzenoid
- Piperidine
- Oxazinane
- Oxane
- 1,3-oxazinane
- Heteroaromatic compound
- Alpha,beta-unsaturated ketone
- Pyrroline
- Pyrrole
- Enone
- Acryloyl-group
- Ketone
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Secondary amine
- Ether
- Oxirane
- Secondary aliphatic amine
- Dialkyl ether
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Kamble SH, Berthold EC, King TI, Raju Kanumuri SR, Popa R, Herting JR, Leon F, Sharma A, McMahon LR, Avery BA, McCurdy CR: Pharmacokinetics of Eleven Kratom Alkaloids Following an Oral Dose of Either Traditional or Commercial Kratom Products in Rats. J Nat Prod. 2021 Apr 23;84(4):1104-1112. doi: 10.1021/acs.jnatprod.0c01163. Epub 2021 Feb 23. [PubMed:33620222 ]
- Flores-Bocanegra L, Raja HA, Graf TN, Augustinovic M, Wallace ED, Hematian S, Kellogg JJ, Todd DA, Cech NB, Oberlies NH: The Chemistry of Kratom [Mitragyna speciosa]: Updated Characterization Data and Methods to Elucidate Indole and Oxindole Alkaloids. J Nat Prod. 2020 Jul 24;83(7):2165-2177. doi: 10.1021/acs.jnatprod.0c00257. Epub 2020 Jun 29. [PubMed:32597657 ]
- Manwill PK, Flores-Bocanegra L, Khin M, Raja HA, Cech NB, Oberlies NH, Todd DA: Kratom (Mitragyna speciosa) Validation: Quantitative Analysis of Indole and Oxindole Alkaloids Reveals Chemotypes of Plants and Products. Planta Med. 2022 Apr 25. doi: 10.1055/a-1795-5876. [PubMed:35468648 ]
- Zhang M, Sharma A, Leon F, Avery B, Kjelgren R, McCurdy CR, Pearson BJ: Effects of Nutrient Fertility on Growth and Alkaloidal Content in Mitragyna speciosa (Kratom). Front Plant Sci. 2020 Dec 21;11:597696. doi: 10.3389/fpls.2020.597696. eCollection 2020. [PubMed:33408731 ]
- Tanna RS, Nguyen JT, Hadi DL, Manwill PK, Flores-Bocanegra L, Layton ME, White JR, Cech NB, Oberlies NH, Rettie AE, Thummel KE, Paine MF: Clinical Pharmacokinetic Assessment of Kratom (Mitragyna speciosa), a Botanical Product with Opioid-like Effects, in Healthy Adult Participants. Pharmaceutics. 2022 Mar 11;14(3). pii: pharmaceutics14030620. doi: 10.3390/pharmaceutics14030620. [PubMed:35335999 ]
- Gutridge AM, Chakraborty S, Varga BR, Rhoda ES, French AR, Blaine AT, Royer QH, Cui H, Yuan J, Cassell RJ, Szabo M, Majumdar S, van Rijn RM: Evaluation of Kratom Opioid Derivatives as Potential Treatment Option for Alcohol Use Disorder. Front Pharmacol. 2021 Nov 3;12:764885. doi: 10.3389/fphar.2021.764885. eCollection 2021. [PubMed:34803709 ]
- Leon F, Obeng S, Mottinelli M, Chen Y, King TI, Berthold EC, Kamble SH, Restrepo LF, Patel A, Gamez-Jimenez LR, Lopera-Londono C, Hiranita T, Sharma A, Hampson AJ, Canal CE, McMahon LR, McCurdy CR: Activity of Mitragyna speciosa ("Kratom") Alkaloids at Serotonin Receptors. J Med Chem. 2021 Sep 23;64(18):13510-13523. doi: 10.1021/acs.jmedchem.1c00726. Epub 2021 Sep 1. [PubMed:34467758 ]
- Hughs M, Kish-Trier E, O'Brien A, McMillin GA: Analysis of Mitragynine and Speciociliatine in Umbilical Cord by LC-MS/MS for Detecting Prenatal Exposure to Kratom. J Anal Toxicol. 2022 Sep 1. pii: 6680066. doi: 10.1093/jat/bkac064. [PubMed:36047661 ]
- Sakamoto J, Kitajima M, Ishikawa H: Asymmetric Total Syntheses of Mitragynine, Speciogynine, and 7-Hydroxymitragynine. Chem Pharm Bull (Tokyo). 2022;70(9):662-668. doi: 10.1248/cpb.c22-00441. [PubMed:36047237 ]
- Karunakaran T, Ngew KZ, Zailan AAD, Mian Jong VY, Abu Bakar MH: The Chemical and Pharmacological Properties of Mitragynine and Its Diastereomers: An Insight Review. Front Pharmacol. 2022 Feb 24;13:805986. doi: 10.3389/fphar.2022.805986. eCollection 2022. [PubMed:35281925 ]
|
---|